Better Mitochondria, Not Just More: Urolithin A’s Human Trial Explained

About this episode

Dr. Mike discusses a landmark study on urolithin A and its implications for mitochondrial health in humans.

In this Deep Dive episode, Dr. Mike breaks down a landmark first-in-human study on urolithin A — one of the most important translational steps yet in mitochondrial longevity science. The paper asks the question the field has been waiting for: when you target mitophagy (the selective cleanup of damaged mitochondria) in real humans, does it appear safe, does it reach the bloodstream and tissue, and does it actually shift biology in the direction of healthier mitochondrial function? You’ll learn why urolithin A is different from typical “mitochondria boosters,” how the study tested safety, tolerability, and bioavailability, and why it matters that urolithin A was detected in skeletal muscle. Dr. Mike also explains the key biomarker signals—like reductions in plasma acylcarnitines — and the muscle gene-expression changes that suggest a coordinated mitochondrial health signature, including comparisons to patterns seen in healthier, more active older adults. The takeaway: this study doesn’t prove performance gains yet — but it strongly supports that mitochondrial quality control is a targetable human biology, and it opens the door for larger efficacy trials. (Educational content only…

People in this episode

Host: Dr. Mike Belkowski

Topics covered

• mitochondrial health
• urolithin A
• mitophagy
• human trial
• longevity science

Keywords

• urolithin A
• mitochondria
• mitophagy
• bioavailability
• muscle gene expression

Mentioned in this episode

Books & works: The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

More episodes of The Energy Code

• The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 2 · June 11, 2026 · 58 min
• MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience · June 8, 2026 · 31 min
• SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source · June 5, 2026 · 15 min
• The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1 · June 4, 2026 · 1h 2m
• Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse · June 3, 2026 · 21 min
• The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch · June 2, 2026 · 15 min